Teva Pharmaceutical
TEVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 3 days ago • TEVA
TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock Up
GlobeNewsWire • 3 days ago • TEVA
Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
Seeking Alpha • 4 days ago • TEVA
Teva Pharmaceutical Industries Limited (TEVA) Q1 2026 Earnings Call Transcript
CNBC Television • 4 days ago • TEVA
Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio
Benzinga • 4 days ago • TEVA
Teva Signals Confidence With $700 Million Pipeline Push, Buyback Plan
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.